ClinicalTrials.gg
Not yet recruitingNCT07936916Updated Nov 13, 2026

Determinants of Physical Activity in Postmenopausal Women

An observational study in Postmenopause and Physical Activity, sponsored by Ondokuz Mayıs University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 45 Years to 64 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-13.

Sponsored by Ondokuz Mayıs University · Observational

Updated Nov 13, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
385
Ages
45 Years to 64 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-14

Among 1,000 studies in Motor Activity with a site in Turkey — 198 open to participants now, 227 under way, none of them phase 3. Motor Activity · Turkey.

Planned enrollment
16th of 228
385 · median 70
Started
2026
with 103 others
Observational
228 of 1,000
37 open now
Primary completion
2027-02
later than 192 of 226 live
Registered
999th of 1,000
by date

Among the 1,000 studies in Motor Activity with a site in Turkey, this one is the 16th largest by planned enrollment of the 228 observational ones that give a count, is one of 104 that started in 2026, is one of 228 observational ones, reaches primary completion later than 192 of the 226 other live ones, and was the 999th registered.

Motor Activity

9,812 studies on the registry are indexed under Motor Activity; 1,917 are open to participants now.

Browse Motor Activity studies →

Open to participants now

198 of the 1,000 studies in Motor Activity with a site in Turkey are open now. Recruiting first, the newest first:

193 more — sign in →

All 198 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 1,204 Motor Activity studies recruiting now, 518 (43%) set no upper age limit and 538 (45%) stop at 75 or younger; 180 take children under 18; 421 take healthy volunteers.

This study: 45 Years to 64 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,000 studies in Motor Activity with a site in Turkey, or all of them as a file.
02

Study summary

In the postmenopausal period, hormonal and physiological changes may be accompanied by alterations in body composition, physical performance, and body image. Psychosocial characteristics such as menopausal symptoms and self-esteem may also be associated with women's physical activity behaviors. During this period, physical activity levels are addressed within a multidimensional framework in which anthropometric, physical, and psychosocial factors are interrelated.

03

Conditions studied

  • Postmenopause
  • Physical Activity

Browse trials for

Keywords

  • Postmenopausal women
  • physical activity
  • CHAID analysis
04

Who can participate

Ages eligible
45 Years to 64 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Community-dwelling postmenopausal women aged 45-64 years who have experienced natural menopause (at least 12 consecutive months without menstruation), are able to walk independently, and voluntarily agree to participate. Women with a history of surgical menopause or conditions that prevent safe completion of the assessments are not included.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Women aged 45-64 years
  • Natural menopause, with no menstruation for at least 12 consecutive months
  • Ability to walk independently
  • Voluntary agreement to participate in the study

Exclusion criteria

Exclusion Criteria:

  • History of surgical menopause
  • Severe neurological, cardiovascular, or musculoskeletal disease that prevents safe completion of the assessments
  • Acute health problem that precludes physical performance testing
  • Inability to complete the assessment forms reliably
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
385 participants (estimated)
Patient registry
No

Groups and cohorts

  • Postmenopausal women

    Postmenopausal women aged 45-64 years

06

What researchers measure

Primary outcomes

  1. Anthropometric Assessment

    Participants' height, body weight, and waist circumference will be measured. Body mass index will be calculated by dividing body weight by the square of height in meters, and waist-to-height ratio will be calculated by dividing waist circumference by height.

    Time frame: Baseline

  2. International Physical Activity Questionnaire Short Form (IPAQ-SF)

    The multinational validity and reliability findings of this questionnaire, developed by an international working group, were published by Craig et al. The Turkish validity and reliability study was conducted by Sağlam et al. The questionnaire provides information about walking, moderate-intensity and vigorous-intensity physical activity, and time spent sitting over the last seven days.

    Time frame: Baseline

  3. Body Cathexis Scale ( BCS)

    The scale, developed by Secord and Jourard, assesses an individual's satisfaction with different parts of the body and bodily functions. The Turkish validity and reliability study was conducted by Hovardaoğlu. The Turkish form consists of 40 items rated on a five-point Likert scale. The total score ranges from 40 to 200, with higher scores indicating decreased satisfaction with the body.

    Time frame: Baseline

  4. Menopause Rating Scale (MRS)

    The international versions and psychometric properties of this scale, developed to assess the severity of menopause-related complaints, were published by Heinemann et al. The Turkish validity and reliability study was conducted by Can Gürkan. The scale consists of 11 items assessing somatic, psychological, and urogenital complaints. Each item is scored from 0 to 4, and the total score ranges from 0 to 44. Higher scores indicate a greater burden of menopausal symptoms.

    Time frame: Baseline

  5. Rosenberg Self-Esteem Scale

    The Turkish adaptation and validity and reliability study of the scale, developed by Rosenberg, was conducted by Çuhadaroğlu. In this study, the 10-item section of the scale assessing self-esteem will be used. The original scoring key of the Turkish adaptation will be followed; the direction and score range of the total score to be used will be finalized before data analysis.

    Time frame: Baseline

  6. Handgrip Strength

    Handgrip strength will be assessed using a Jamar hand dynamometer. The participant will be positioned in an upright seated posture with the arm alongside the trunk, the elbow flexed at 90°, and the forearm supported on a horizontal surface. The measurement will be performed three times for each hand, with a rest period of 30-60 seconds between consecutive trials. During each trial, the participant will be verbally encouraged to produce maximal grip force. The highest value obtained from the three measurements for each hand will be recorded in kilograms (kg).

    Time frame: Baseline

  7. 30-Second Sit-to-Stand Test (STS)

    Lower extremity functional performance will be assessed using the 30-Second Sit-to-Stand Test. After 1-2 practice trials and a 30-60 second rest, participants will perform the test on a standard armless chair (seat height 45 cm) with arms crossed over the chest, standing up fully and sitting down as many times as possible in 30 seconds. The number of correct repetitions will be recorded, and participants may stop if they feel excessive fatigue. Sit-to-stand (STS) muscle power will be calculated in watts (W) using the equation defined by Alcazar et al., and relative STS muscle power (W/kg) will be obtained by dividing it by body weight.

    Time frame: Baseline

07

Study locations

1 site
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Nov 2026; primary completion for Feb 2027, 3 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 7, 2026
First posted
Nov 13, 2026
StartEst.
Nov 15, 2026
Primary completionEst.
Feb 15, 2027
CompletionEst.
Feb 28, 2027
Last update
Nov 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 13, 2026
Show all 1 update
  1. Nov 13, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07936916
Responsible party
Seda Nur Kemer (PT, PhD, Lecturer, Ondokuz Mayıs University) — Principal investigator
First posted
Nov 13, 2026
Start date
Nov 15, 2026 (estimated)
Primary completion
Feb 15, 2027 (estimated)
Completion
Feb 28, 2027 (estimated)
Last update
Nov 13, 2026

Study contacts

Seda Nur Kemer PT, PhD, Lecturer, PT, PhD
Contact
sedanur.kemer@omu.edu.tr
+90 362 312 1919

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion